Accessing Collaborative Cancer Research in Montana
GrantID: 68668
Grant Funding Amount Low: $150,000
Deadline: October 14, 2026
Grant Amount High: $150,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Awards grants, Business & Commerce grants, Education grants, Financial Assistance grants, Health & Medical grants, Higher Education grants.
Grant Overview
Target Outcomes for Cancer Biomarker Research in Montana
The Grants for Adapting Cancer Biomarkers for Clinical Validation Projects prioritizes specific outcomes to enhance cancer detection and treatment in Montana. The primary goal is to support projects that validate innovative molecular, cellular, and imaging markers for predicting treatment responses and monitoring disease progression. By focusing on the clinical validation of biomarkers, the grant aims to bridge the gap between research and practical application in cancer care.
Improving Cancer Diagnosis and Treatment Outcomes
One of the key outcomes targeted by this grant is the improvement of cancer diagnosis accuracy and treatment efficacy. Montana's rural landscape and limited access to specialized healthcare services in frontier counties make it an ideal location for projects that can enhance cancer detection and treatment through advanced biomarker technologies. For instance, projects that develop and validate biomarkers for early cancer detection can significantly improve patient outcomes in regions with limited healthcare resources.
The Montana Department of Public Health and Human Services, through its Chronic Disease Prevention and Health Promotion Program, works closely with healthcare providers and researchers to address cancer disparities across the state. This grant aligns with the department's efforts to improve cancer screening and treatment outcomes, particularly in rural and underserved areas.
Advancing Precision Medicine in Montana
Another critical outcome of this grant is the advancement of precision medicine in Montana. By supporting the clinical validation of biomarkers that predict treatment responses, the grant enables healthcare providers to tailor treatments to individual patients based on their unique genetic and molecular profiles. This approach is particularly relevant in Montana, where the diverse population and geographic spread necessitate personalized healthcare solutions.
The University of Montana's Center for Translational Medicine is a key player in advancing precision medicine in the state. The center's research focuses on developing and applying cutting-edge technologies, including biomarker-based diagnostics, to improve healthcare outcomes. Projects funded by this grant can leverage the center's expertise and resources to accelerate the clinical validation of cancer biomarkers.
Measuring Success in Cancer Biomarker Research
To measure the success of projects funded under this grant, the funder will assess the extent to which the validated biomarkers improve cancer diagnosis and treatment outcomes. Key performance indicators may include the number of patients benefiting from biomarker-guided treatments, improvements in cancer survival rates, and the reduction in healthcare costs associated with unnecessary treatments or delayed diagnoses.
Applicants should be aware that the grant review process will prioritize projects that demonstrate a clear potential for clinical impact and scalability. Proposals that address the unique challenges faced by Montana's healthcare system, such as limited access to specialized services in rural areas, are likely to be favorably considered.
Q: What types of cancer biomarkers are most likely to be funded under this grant? A: The grant is open to a wide range of cancer biomarkers, including molecular, cellular, and imaging markers, with a focus on those that can be used to predict treatment responses and monitor disease progression.
Q: How can small businesses in Montana access this grant funding? A: Small businesses can apply for this grant by submitting a proposal that outlines their project plan, including the development and clinical validation of cancer biomarkers, and demonstrates how their project aligns with the grant's priority outcomes.
Q: Are there any specific resources available to help Montana nonprofits navigate the grant application process? A: Yes, the Montana Nonprofit Association provides resources and support to nonprofits, including guidance on grant writing and application processes. Nonprofits can reach out to the association for assistance in preparing their grant proposals.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grant for Cancer Screening Access in Disadvantaged Communities
The grant focuses on addressing significant health disparities in vulnerable populations. The fund a...
TGP Grant ID:
68669
Grant for Boost Sustainable Agriculture Through Research and Education
The grants aim to increase the adoption of sustainable agricultural practices by overcoming environm...
TGP Grant ID:
68671
Grant to Support Initiatives in Health, Education, and Social Justice
This grant program supports projects that address key needs aligned with the Foundation's missio...
TGP Grant ID:
68675
Grant for Cancer Screening Access in Disadvantaged Communities
Deadline :
2027-01-07
Funding Amount:
Open
The grant focuses on addressing significant health disparities in vulnerable populations. The fund aims to develop and implement innovative strategies...
TGP Grant ID:
68669
Grant for Boost Sustainable Agriculture Through Research and Education
Deadline :
2024-11-06
Funding Amount:
$0
The grants aim to increase the adoption of sustainable agricultural practices by overcoming environmental, economic, and social barriers. The program&...
TGP Grant ID:
68671
Grant to Support Initiatives in Health, Education, and Social Justice
Deadline :
Ongoing
Funding Amount:
$0
This grant program supports projects that address key needs aligned with the Foundation's mission to promote human health, dignity, and the pursui...
TGP Grant ID:
68675